- Nutritional Growth Solutions has appointed David Fenlon as an Independent Non-Executive Chairman
- NGS develops scientifically formulated and clinically proven supplements to support growth development in children
- Fenlon has rich experience of more than 30 years in retail and consumer goods and will take over from founding Chairman, Brian Leedman.
Global nutritional health company, Nutritional Growth Solutions Ltd. (ASX: NGS) has appointed industry veteran, David Fenlon as Independent Non-Executive Chairman effective immediately.
Mr Fenlon will bring his extensive experience of more than 30 years in retail and consumer goods across Europe, North America and Australasia to the NGS Board.
Until recently, he served as Managing Director and Chief Executive Officer (CEO) of BWX Limited (ASX: BWX), a leading beauty and wellness business and was previously the Managing Director – Australia and New Zealand for Blackmores Limited (ASX: BKL).
Commenting on his appointment, Fenlon said:
Founding Chairman of NGS, Brian Leedman to step down
Nutritional Growth Solutions has appointed Fenlon after founding Chairman, Brian Leedman announced his resignation from the Board. Leedman has contributed immensely to NGS including navigating the Company through its public listing process.
Mr Leedman will stay associated with NGS and continue to contribute in a consulting capacity. His Performance Rights will not expire as of now and instead, will hold the rights until the end of his consultancy.
Mr Leedman said, “With the appointment of David as NGS’ new Chairman, and the incredible experience he brings to the Company, I look forward to seeing NGS’ further development and growth and continuing to be a supportive shareholder.”
Nutritional Growth Solutions develops scientifically formulated and clinically proven supplements to support growth development in children. NGS has made significant progress since listing on the Australian Securities Exchange (ASX), entering new markets, expanding distribution channels and launching new products that are clinically tested to support growth development in children.